Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al., Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49: 498-547.
Chen IL, Gao WY, Johnson AP, Niak A, Troiani J, Korvick J, et al., Proton pump inhibitor use in infants: FDA reviewer experience. J Pediatr Gastroenterol Nutr 2012; 54: 8-14.
Quigley EM,. Cisapride: what can we learn from the rise and fall of a prokinetic? J Dig Dis 2011; 12: 147-56.
Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J,. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000; 102: 1883-5.
Djeddi D, Kongolo G, Lefaix C, Mounard J, Léké A,. Effect of domperidone on QT interval in neonates. J Pediatr 2008; 153: 663-6.
Ward OC,. New familial cardiac syndrome in children. J Ir Med Assoc 1964; 54: 103-6.
Jervell A, Lange-Nielsen F,. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957; 54: 59-68.
Ahmad N, Keith-Ferris J, Gooden E, Abell T,. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol 2006; 6: 571-6.
De Loore L, Van Ravenstayn H,. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J 1979; 55 (Suppl 1): 40-2.
Clara R,. Chronic regurgitation and vomiting treated with domperidone. A multicenter evaluation. Acta Paediatr Belg 1979; 32: 203-7.
Carroccio A, Laccono G, Montalto G, Cavatajo F, Soresi M, Notararbartolo A,. Domperidone plus magnesium hydroxide and aluminium hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomised study versus placebo. Scand J Gastroenterol 1994; 4: 300-4.
Pritchard DS, Baber N, Stephenson T,. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old Br J Clin Pharmacol 2005; 59: 725-9.
Hondeghem LM,. Low safety index of domperidone: mechanism for increased odds ratio for sudden cardiac death. Acta Cardiol 2011; 66: 421-5.
Rocha CM, Barbosa MM,. QT interval prolongation associated with the oral use of domperidone in an infant. Pediatr Cardiol 2005; 26: 720-3.
van Noord C, Dieleman JP, van Herpen G, Verhamme K, Sturkenboom MC,. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf 2010; 33: 1003-14.
Rossi M, Giorgi G,. Domperidone and long QT syndrome. Curr Drug Saf 2010; 5: 257-62.
Albano F, Bruzzese E, Spagnuolo MI, De Marco G,. Antiemetics for children with gastroenteritis: off-label but still on in clinical practice. J Pediatr Gastroenterol Nutr 2006; 43: 402-4.
Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, et al., European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 2008; 46 (Suppl 2): S81-122.
Günlemez A, Babaoglu A, Artsoy AE, Tûrker G, Gökalp AS,. Effect of domperdidone on the QTc interval in premature infants. J Perinatol 2010; 30: 50-3.
Hegar B, Alatas S, Advani N, Firmansyah A, Vandenplas Y,. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study. Acta Paediatr 2009; 98: 750-5.
